The use of gadolinium (Gd) based contrast agents is being questioned due to its recently discovered retention in healthy individuals following administration. Our newest generation x-ray fluorescence system has been used in a small pilot study for in vivo Gd measurements in bones of healthy individuals, who have previously received these contrast agents. Preliminary results show a significant difference between the Gd-exposed and control groups, suggesting Gd accumulation in healthy individuals. Our system has performed the first human in vivo measurement of Gd in bone and has the potential to be used in further studies of accumulation in the body.
This abstract and the presentation materials are available to members only; a login is required.